FDA Closes Recall of Accord Healthcare Levothyroxine Tablets
The FDA has closed the Class II recall of certain levothyroxine sodium tablets distributed nationwide.
2 reports on this incident · first at Sep 7, 2026, 9:51 p.m. ET
Earlier reports
Sep 7, 2026, 9:51 p.m. ETFirst report
Accord Healthcare Recalls Levothyroxine Sodium Tablets Due to Subpotency
Accord Healthcare, Inc. of Raleigh, NC, initiated a recall of Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) on August 6, 2026, according to an FDA enforcement report dated September 2, 2026. The recall, listed as Class II and ongoing, covers specific lots distributed nationwide within the United States.
The affected product is packaged in 90-count bottles (NDC 16729-456-15) and 1000-count bottles (NDC 16729-456-17). The recall includes lot numbers D2402642 (exp. 11/30/2026), D2401832 (exp. 08/31/2026), and D2402525, D2402527, D2402526, D2402644, D2402643 (all exp. 11/30/2026). The reason for the recall is listed as "Subpotent Drug."
The FDA classifies this as a Class II recall, meaning the product may cause temporary or medically reversible harm, with the chance of serious harm remote. Accord Healthcare's database shows no other enforcement actions by the firm.
Was this report accurate and useful?
Sources
Revision history
- Version 18 Sept 2026, 01:51current
First published.
- Version 18 Sept 2026, 01:53current
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.